Dr. Le Roux is Ireland-based University College Dublin’s head of pathology. Dr. Greve is the medical director of the Dutch Obesity Clinic in the Netherlands.
Here’s what you should know.
1. The advisory group is assisting GI Dynamics in its attempt to earn FDA approval for its EndoBarrier device.
2. The EndoBarrier is an endoscopically delivered device approved for type 2 diabetes and obesity treatment.
3. The EndoBarrier is currently only available for investigational use in the United States.
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Mark Milone of Midwest Family Care
Colorectal cancer screening rates on the rise: 4 fast stats
Novel endoscopic device used for esophageal cancer diagnosis, staging: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
